Tower Research Capital (TRC)’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,115
Closed -$74K 4813
2019
Q3
$74K Buy
7,115
+5,583
+364% +$58.1K 0.01% 1533
2019
Q2
$23K Buy
+1,532
New +$23K ﹤0.01% 2104
2018
Q4
Sell
-444
Closed -$7K 4639
2018
Q3
$7K Sell
444
-1,558
-78% -$24.6K ﹤0.01% 2997
2018
Q2
$32K Buy
+2,002
New +$32K ﹤0.01% 2137
2018
Q1
Sell
-584
Closed -$9K 4209
2017
Q4
$9K Sell
584
-2,325
-80% -$35.8K ﹤0.01% 2646
2017
Q3
$33K Buy
2,909
+2,839
+4,056% +$32.2K ﹤0.01% 2372
2017
Q2
$1K Sell
70
-1,681
-96% -$24K ﹤0.01% 2566
2017
Q1
$15K Buy
1,751
+1,294
+283% +$11.1K ﹤0.01% 1509
2016
Q4
$5K Buy
+457
New +$5K ﹤0.01% 3099
2016
Q3
Sell
-1,015
Closed -$7K 4858
2016
Q2
$7K Sell
1,015
-4,192
-81% -$28.9K ﹤0.01% 3196
2016
Q1
$24K Buy
5,207
+2,265
+77% +$10.4K ﹤0.01% 1233
2015
Q4
$19K Buy
2,942
+117
+4% +$756 ﹤0.01% 1373
2015
Q3
$25K Buy
2,825
+2,165
+328% +$19.2K ﹤0.01% 1561
2015
Q2
$8K Sell
660
-743
-53% -$9.01K ﹤0.01% 2933
2015
Q1
$20K Buy
1,403
+239
+21% +$3.41K ﹤0.01% 2263
2014
Q4
$20K Sell
1,164
-1,584
-58% -$27.2K ﹤0.01% 1608
2014
Q3
$34K Buy
2,748
+424
+18% +$5.25K ﹤0.01% 1871
2014
Q2
$34K Buy
+2,324
New +$34K ﹤0.01% 1526
2014
Q1
Sell
-1,470
Closed -$29K 5206
2013
Q4
$29K Buy
+1,470
New +$29K ﹤0.01% 1935
2013
Q3
Sell
-470
Closed -$12K 4980
2013
Q2
$12K Buy
+470
New +$12K ﹤0.01% 2225